Eugenol prevents amyloid formation of proteins and inhibits amyloid-induced hemolysis. - GreenMedInfo Summary
Eugenol prevents amyloid formation of proteins and inhibits amyloid-induced hemolysis.
Sci Rep. 2017 Feb 1 ;7:40744. Epub 2017 Feb 1. PMID: 28145454
Eugenol has attracted considerable attention because of its potential for many pharmaceutical applications including anti-inflammatory, anti-tumorigenic and anti-oxidant properties. Here, we have investigated the effect of eugenol on amyloid formation of selected globular proteins. We find that both spontaneous and seed-induced aggregation processes of insulin and serum albumin (BSA) are significantly suppressed in the presence of eugenol. Isothermal titration calorimetric data predict a single binding site for eugenol-insulin complex confirming the affinity of eugenol for native soluble insulin species. We also find that eugenol suppresses amyloid-induced hemolysis. Our findings reveal the inherent ability of eugenol to stabilize native proteins and to delay the conversion of protein species of native conformation intoβ-sheet assembled mature fibrils, which seems to be crucial for its inhibitory effect.